StonvexLoading…
StonvexStonvexStonvexCore line items from IEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.46B | $3.27B | $3.27B | $3.18B |
Operating Income | $699.30M | $677.20M | $732.50M | $751.40M |
Net Income | $483.20M | $505.00M | $596.10M | $586.90M |
EPS (Diluted) | $6.41 | $6.64 | $7.85 | $7.71 |
Total Assets | $6.93B | $6.75B | $5.87B | $5.51B |
Total Liabilities | $2.90B | $2.95B | $2.32B | $2.47B |
Cash & Equivalents | $580.00M | $620.80M | $534.30M | $430.20M |
Free Cash Flow OCF − CapEx | $616.80M | $603.00M | $626.80M | $489.40M |
Shares Outstanding | 75.30M | 75.90M | 75.90M | 76.00M |